Community-based intervention to reduce tuberculosis among people who inject drugs in Vietnam

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research aims to implement a targeted, multi-component community-based intervention to decrease tuberculosis (TB) prevalence among people who inject drugs (PWID) in Hai Phong, Vietnam. The study will utilize repeated large-scale randomized driven sampling surveys to identify TB-infected PWID and assess their symptoms through questionnaires, CRP tests, chest X-rays, and sputum collection. The intervention is designed to enhance community involvement and improve access to TB care for this high-risk population, which has shown alarming TB prevalence rates. The study builds on previous findings that highlighted the significant TB burden among PWID in Vietnam.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years of age or older
* Self-declaring injecting heroin or any other drug
* Positive urine test for heroin or methamphetamine
* Presence of recent injection site marks

Exclusion Criteria:

* Unable to understand or refused to sign informed consent
* Patients currently under treatment for active TB
* Any condition which might, in the investigator's opinion, compromise the safety of the patient by participating in the study, including very severe clinical condition
* Person deprived of freedom by a judicial or administrative decision

Where it's running

• Hai Phong University of Medecine and Pharmacy
  Haiphong, Vietnam Recruiting
• Viettiep 2 Hospital
  Haiphong, Vietnam Recruiting

Study contacts

• Principal investigator: Nicolas NAGOT — PCCI UMR 1058 - INSERM, Univ Montpellier, EFS, Montpellier, Franc
• Study coordinator: Marion BONNETON
• Email: marion.bonneton@inserm.fr
• Phone: +84344755013

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Doxycycline added to standard treatment for central nervous system tuberculosis

  This trial tests whether adding doxycycline to standard anti‑TB therapy and corticosteroids helps adults with central nervous system tuberculosis live longer or have less severe neurological disability.

  Recruiting at 5 sites Phase 2 National University Hospital, Singapore · Medan, Medan and 5 other locations · NCT06446245

• Biomarker Test for Diagnosis and Monitoring of Extrapulmonary Tuberculosis

  This study tests biomarker-based methods to help diagnose extrapulmonary TB and monitor treatment in adults, including people living with HIV, using samples from affected sites in Kenya.

  Recruiting at 2 sites Nagasaki University · Nairobi and 1 other locations · NCT07901387

• Short-Course TB Treatment for Children with Non-Severe Pulmonary TB

  This trial tests two shorter-treatment options for kids with non-severe pulmonary TB to see if they can clear the infection as well as the standard 6-month plan.

  Recruiting at 13 sites Phase 2 Huashan Hospital · Fuzhou, Fujian and 12 other locations · NCT07893444

• Combined oral contraceptive timing with Ganfeborole in healthy women

  This study tests how the contraceptive Microgynon behaves in the body when given alone and with Ganfeborole in healthy women who can’t get pregnant.

  Recruiting Phase 1 GlaxoSmithKline · Madrid · NCT07784894

• Isoniazid inhalation in TB patients: a first-in-human look at local tolerability and body levels

  This early study tests inhaled isoniazid to see how well it tolerates the lungs and how it behaves in the body in adults with tuberculosis.

  Recruiting Phase 1 University Medical Center Groningen · Groningen · NCT07708779

• How the immune system responds to mycobacterial infections

  This study tests how the immune system changes in people with tuberculosis and related mycobacterial infections.

  Recruiting First Affiliated Hospital of Ningbo University · Ningbo · NCT07638670

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.